Pneumonia Vaccine – Ages 65– 85
PMG Research of Wilmington
A research study is evaluating an investigational pneumonia vaccine compared to an FDA-approved comparator vaccine.
This research study may be an option if you:
• Have never received a pneumonia vaccine
Have received Prevnar 13® ten months to two years ago
• Are generally healthy (any chronic diseases should be controlled and stable)
• Have no immune disorders including autoimmune diseases
• Have access to prior immunization records
Other criteria apply. Please make sure to discuss with a member of our research staff to ensure this research study is a good fit for you.
Qualified participants will receive all study-related care and the study vaccine or FDA-approved comparator at no cost.
Patient Commitment Duration
Approximately 6 months
Financial reimbursement will be provided for time and travel expenses.
Number of visits in study
Approximately 4 clinic visits and 1 phone call